Edition:
United Kingdom

Strides Pharma Science Ltd (SRID.NS)

SRID.NS on National Stock Exchange of India

517.25INR
18 Jan 2019
Change (% chg)

Rs-11.15 (-2.11%)
Prev Close
Rs528.40
Open
Rs527.30
Day's High
Rs529.40
Day's Low
Rs504.50
Volume
1,678,240
Avg. Vol
1,501,339
52-wk High
Rs828.30
52-wk Low
Rs333.30

Latest Key Developments (Source: Significant Developments)

Strides Pharma Science Gets USFDA Approval For Lidocaine Ointment
Wednesday, 12 Dec 2018 

Dec 12 (Reuters) - Strides Pharma Science Ltd ::SAYS RECEIVES USFDA APPROVAL FOR LIDOCAINE OINTMENT.  Full Article

Strides Pharma Science Says Unit Enters Into Strategic Partnership With SUDA Pharmaceuticals
Friday, 9 Nov 2018 

Nov 9 (Reuters) - Strides Pharma Science Ltd ::STRIDES ENTERS INTO A STRATEGIC PARTNERSHIP WITH SUDA PHARMACEUTICALS FOR US MARKET.  Full Article

Strides Pharma Science Says Unit Got USFDA Nod For Potassium Chloride Extended Release Tablets
Wednesday, 5 Sep 2018 

Sept 5 (Reuters) - Strides Pharma Science Ltd ::STRIDES PHARMA GLOBAL PTE. LTD SINGAPORE GOT USFDA NOD FOR POTASSIUM CHLORIDE EXTENDED RELEASE TABLETS.PRODUCT WILL BE MANUFACTURED AT CO'S FACILITY AT BANGALORE AND MARKETED BY STRIDES PHARMA INC. IN THE US MARKET.  Full Article

Strides Shasun Gets U.S. FDA Approval For Ibuprofen OTC Tablets
Monday, 2 Jul 2018 

July 2 (Reuters) - Strides Shasun Ltd ::SAYS CO GETS U.S. FDA APPROVAL FOR IBUPROFEN OTC TABLETS.  Full Article

Strides Shasun Gets USFDA Tentative Approval For Milnacipran Hydrochloride Tablets
Monday, 2 Jul 2018 

July 2 (Reuters) - Strides Shasun Ltd ::SAYS STRIDES SHASUN RECEIVES USFDA TENTATIVE APPROVAL FOR MILNACIPRAN HYDROCHLORIDE TABLETS.  Full Article

Strides Shasun Gets WHO Prequalification for Rectal Artesunate Product
Thursday, 21 Jun 2018 

June 21 (Reuters) - Strides Shasun Ltd ::SAYS CO'S RECTAL ARTESUNATE PRODUCT RECEIVES WHO PREQUALIFICATION.PREQUALIFICATION FOR RECTAL ARTESUNATE SUPPOSITORIES (RAS) FOR PRE-REFERRAL MANAGEMENT OF SEVERE MALARIA.  Full Article

Strides Shasun Appoints Arun Kumar As Group CEO And MD
Friday, 18 May 2018 

May 18 (Reuters) - Strides Shasun Ltd ::SAYS ARUN KUMAR TO BE GROUP CEO AND MANAGING DIRECTOR OF THE COMPANY .SAYS DEEPAK VAIDYA TO BE THE CHAIRMAN OF THE BOARD OF DIRECTORS OF THE COMPANY.  Full Article

India's Strides Shasun March-Qtr Consol Profit Rises Five-Fold
Friday, 18 May 2018 

May 18 (Reuters) - Strides Shasun Ltd ::MARCH QUARTER CONSOL NET PROFIT 5.68 BILLION RUPEES VERSUS PROFIT OF 1.12 BILLION RUPEES LAST YEAR.MARCH QUARTER CONSOL REVENUE FROM OPERATIONS 6.64 BILLION RUPEES VERSUS 6.77 BILLION RUPEES LAST YEAR.  Full Article

India's Strides Shasun Gets U.S. FDA Nod For Cinacalcet Hydrochloride Tablets
Wednesday, 2 May 2018 

May 2 (Reuters) - Strides Shasun Ltd ::STRIDES SHASUN RECEIVES USFDA APPROVAL FOR CINACALCET HYDROCHLORIDE TABLETS.PRODUCT WILL BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY AT PUDUCHERRY.PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN THE U.S. MARKET.  Full Article

India's Strides Shasun Gets U.S. FDA Nod For Cyproheptadine Hydrochloride Tablets
Thursday, 12 Apr 2018 

April 12 (Reuters) - Strides Shasun Ltd ::GETS USFDA APPROVAL FOR CYPROHEPTADINE HYDROCHLORIDE TABLETS.PRODUCT WILL BE MANUFACTURED AT ORAL DOSAGE FACILITY AT BANGALORE.PRODUCT WILL BE MARKETED BY STRIDES PHARMA INC IN U.S MARKET.SAYS DRUG IS INDICATED TO RELIEVE ALLERGY SYMPTOMS.  Full Article